162 related articles for article (PubMed ID: 23006485)
1. Genetic and pharmacological modulation of giant depolarizing potentials in the neonatal hippocampus associates with increased seizure susceptibility.
Vargas E; Petrou S; Reid CA
J Physiol; 2013 Jan; 591(1):57-65. PubMed ID: 23006485
[TBL] [Abstract][Full Text] [Related]
2. The cation-chloride cotransporter NKCC1 promotes sharp waves in the neonatal rat hippocampus.
Sipilä ST; Schuchmann S; Voipio J; Yamada J; Kaila K
J Physiol; 2006 Jun; 573(Pt 3):765-73. PubMed ID: 16644806
[TBL] [Abstract][Full Text] [Related]
3. Bumetanide, an NKCC1 antagonist, does not prevent formation of epileptogenic focus but blocks epileptic focus seizures in immature rat hippocampus.
Nardou R; Ben-Ari Y; Khalilov I
J Neurophysiol; 2009 Jun; 101(6):2878-88. PubMed ID: 19297515
[TBL] [Abstract][Full Text] [Related]
4. Astrocytic NKCC1 inhibits seizures by buffering Cl
Nguyen TD; Ishibashi M; Sinha AS; Watanabe M; Kato D; Horiuchi H; Wake H; Fukuda A
Epilepsia; 2023 Dec; 64(12):3389-3403. PubMed ID: 37779224
[TBL] [Abstract][Full Text] [Related]
5. Compensatory enhancement of intrinsic spiking upon NKCC1 disruption in neonatal hippocampus.
Sipilä ST; Huttu K; Yamada J; Afzalov R; Voipio J; Blaesse P; Kaila K
J Neurosci; 2009 May; 29(21):6982-8. PubMed ID: 19474325
[TBL] [Abstract][Full Text] [Related]
6. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.
Kahle KT; Staley KJ
Neurosurg Focus; 2008 Sep; 25(3):E22. PubMed ID: 18759624
[TBL] [Abstract][Full Text] [Related]
7. Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy.
Brandt C; Seja P; Töllner K; Römermann K; Hampel P; Kalesse M; Kipper A; Feit PW; Lykke K; Toft-Bertelsen TL; Paavilainen P; Spoljaric I; Puskarjov M; MacAulay N; Kaila K; Löscher W
Neuropharmacology; 2018 Dec; 143():186-204. PubMed ID: 30248303
[TBL] [Abstract][Full Text] [Related]
8. Bumetanide enhances phenobarbital efficacy in a neonatal seizure model.
Dzhala VI; Brumback AC; Staley KJ
Ann Neurol; 2008 Feb; 63(2):222-35. PubMed ID: 17918265
[TBL] [Abstract][Full Text] [Related]
9. Temperature elevation increases GABA(A) -mediated cortical inhibition in a mouse model of genetic epilepsy.
Hill EL; Hosie S; Mulligan RS; Richards KL; Davies PJ; Dubé CM; Baram TZ; Reid CA; Jones MV; Petrou S
Epilepsia; 2011 Jan; 52(1):179-84. PubMed ID: 21219304
[TBL] [Abstract][Full Text] [Related]
10. Abnormal GABAA receptor-mediated currents in dorsal root ganglion neurons isolated from Na-K-2Cl cotransporter null mice.
Sung KW; Kirby M; McDonald MP; Lovinger DM; Delpire E
J Neurosci; 2000 Oct; 20(20):7531-8. PubMed ID: 11027211
[TBL] [Abstract][Full Text] [Related]
11. Excitatory actions of GABA in the intact neonatal rodent hippocampus in vitro.
Valeeva G; Valiullina F; Khazipov R
Front Cell Neurosci; 2013; 7():20. PubMed ID: 23467988
[TBL] [Abstract][Full Text] [Related]
12. NKCC1 transporter facilitates seizures in the developing brain.
Dzhala VI; Talos DM; Sdrulla DA; Brumback AC; Mathews GC; Benke TA; Delpire E; Jensen FE; Staley KJ
Nat Med; 2005 Nov; 11(11):1205-13. PubMed ID: 16227993
[TBL] [Abstract][Full Text] [Related]
13. Thermodynamic regulation of NKCC1-mediated Cl- cotransport underlies plasticity of GABA(A) signaling in neonatal neurons.
Brumback AC; Staley KJ
J Neurosci; 2008 Feb; 28(6):1301-12. PubMed ID: 18256250
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic efficacy of bumetanide in an in vitro model of posttraumatic epileptogenesis.
Dzhala V; Staley KJ
CNS Neurosci Ther; 2015 Feb; 21(2):173-80. PubMed ID: 25495911
[TBL] [Abstract][Full Text] [Related]
15. Model-specific effects of bumetanide on epileptiform activity in the in-vitro intact hippocampus of the newborn mouse.
Kilb W; Sinning A; Luhmann HJ
Neuropharmacology; 2007 Sep; 53(4):524-33. PubMed ID: 17681355
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of bumetanide at brain concentrations incompatible with NKCC1 inhibition on newborn DGC structure and spontaneous EEG seizures following hypoxia-induced neonatal seizures.
Wang S; Zhang XQ; Song CG; Xiao T; Zhao M; Zhu G; Zhao CS
Neuroscience; 2015 Feb; 286():203-15. PubMed ID: 25463517
[TBL] [Abstract][Full Text] [Related]
17. Developmental changes in GABAergic actions and seizure susceptibility in the rat hippocampus.
Khazipov R; Khalilov I; Tyzio R; Morozova E; Ben-Ari Y; Holmes GL
Eur J Neurosci; 2004 Feb; 19(3):590-600. PubMed ID: 14984409
[TBL] [Abstract][Full Text] [Related]
18. The Pharmacological Assessment of GABA
Kasahara Y; Igata H; Sasaki T; Ikegaya Y; Koyama R
eNeuro; 2019; 6(1):. PubMed ID: 31058209
[TBL] [Abstract][Full Text] [Related]
19. Epileptiform activity triggers long-term plasticity of GABA(B) receptor signalling in the developing rat hippocampus.
Tosetti P; Ferrand N; Colin-Le Brun I; Gaïarsa JL
J Physiol; 2005 Nov; 568(Pt 3):951-66. PubMed ID: 16096337
[TBL] [Abstract][Full Text] [Related]
20. NKCC1 and KCC2 prevent hyperexcitability in the mouse hippocampus.
Zhu L; Polley N; Mathews GC; Delpire E
Epilepsy Res; 2008 May; 79(2-3):201-12. PubMed ID: 18394864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
